Neuraxis (NRXS) Shares Outstanding (Entity) (2022 - 2026)
Neuraxis (NRXS) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.73 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 218.28 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 575.47 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 252.88 Mn |
| 10 | Neuraxis | 75.51 Mn | 67.18 Mn | - | 12.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.47 Mn |
| Mar 31, 2026 | 11.45 Mn |
| Dec 31, 2025 | 10.65 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 9.86 Mn |
| Mar 31, 2025 | 7.22 Mn |
| Dec 31, 2024 | 6.99 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Mar 31, 2024 | 6.59 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 1.94 Mn |